Literature DB >> 28285335

Cell type-dependent regulation of free ISG15 levels and ISGylation.

Angeles C Tecalco Cruz1, Karen Mejía-Barreto2.   

Abstract

Interferon-stimulated gene 15 (ISG15) is an ubiquitin-like protein, which can either be found as a free protein or covalently-bound to target proteins via ISGylation. The functions of free and conjugated ISG15 are ambiguous in tumorigenesis owing to its roles as an oncogene and a tumour suppressor gene. This dual role for ISG15 could be a result of the cancer cell type and the cellular context. Here, we report that ISG15 expression is upregulated in different cancer cells compared to normal cells. Furthermore, we found higher endogenous, free ISG15 protein levels in MCF7 breast cancer cells than in other cells, suggesting that non-conjugated ISG15 levels are cell type-specific. Additionally, we demonstrated that interferon gamma (IFN-Ɣ) increased both free and conjugated levels of ISG15 in MCF7 cells. Interestingly, endogenous conjugated and free ISG15 levels were differentially regulated by IFN-Ɣ in several cell lines. On characterisation of the subcellular distribution of ISG15 in several cell types, our results indicated that free ISG15 was mainly localised to the cytoplasm of MCF7 cells, whereas ISGylation marks were also found in the cytoplasm, but mainly in the nucleus, with a specific distribution pattern in each cell type. Thus, free and conjugated ISG15 protein levels and their subcellular distribution are cell type-dependent, whereas IFN-Ɣ signalling may differentially control the abundance of both ISG15 forms in transformed and normal cells.

Entities:  

Keywords:  Free ISG15; IFN-Ɣ; ISGylation; Subcellular distribution; Transformed and normal cells

Year:  2017        PMID: 28285335      PMCID: PMC5440350          DOI: 10.1007/s12079-017-0385-7

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  48 in total

1.  Role of interferon-stimulated gene ISG-15 in the interferon-omega-mediated inhibition of human immunodeficiency virus replication.

Authors:  M S Künzi; P M Pitha
Journal:  J Interferon Cytokine Res       Date:  1996-11       Impact factor: 2.607

2.  Precursor processing of pro-ISG15/UCRP, an interferon-beta-induced ubiquitin-like protein.

Authors:  J L Potter; J Narasimhan; L Mende-Mueller; A L Haas
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

Review 3.  The two faces of interferon-γ in cancer.

Authors:  M Raza Zaidi; Glenn Merlino
Journal:  Clin Cancer Res       Date:  2011-06-24       Impact factor: 12.531

4.  Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway.

Authors:  Shyamal D Desai; Arthur L Haas; Laurence M Wood; Yu-Chen Tsai; Sidney Pestka; Eric H Rubin; Ahamed Saleem; Alam Nur-E-Kamal; Leroy F Liu
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

5.  The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein.

Authors:  Chen Zhao; Sylvie L Beaudenon; Melissa L Kelley; M Brett Waddell; Weiming Yuan; Brenda A Schulman; Jon M Huibregtse; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-06       Impact factor: 11.205

6.  Immunoregulatory properties of ISG15, an interferon-induced cytokine.

Authors:  J D'Cunha; E Knight; A L Haas; R L Truitt; E C Borden
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

7.  Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective.

Authors:  Julian Burks; Ryan E Reed; Shyamal D Desai
Journal:  Oncotarget       Date:  2015-03-30

8.  ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma.

Authors:  Ren-Hui Chen; Yong Du; Ping Han; Hong-Bo Wang; Fa-Ya Liang; Guo-Kai Feng; Ai-Jun Zhou; Mu-Yan Cai; Qian Zhong; Mu-Sheng Zeng; Xiao-Ming Huang
Journal:  Oncotarget       Date:  2016-03-29

9.  Oncogene-mediated regulation of p53 ISGylation and functions.

Authors:  Yi-Fu Huang; Dmitry V Bulavin
Journal:  Oncotarget       Date:  2014-07-30

10.  Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification.

Authors:  Jong Ho Park; Seung Wook Yang; Jung Mi Park; Seung Hyeun Ka; Ji-Hoon Kim; Young-Yun Kong; Young Joo Jeon; Jae Hong Seol; Chin Ha Chung
Journal:  Nat Commun       Date:  2016-08-22       Impact factor: 14.919

View more
  5 in total

1.  Enhancement of HIV-1 Env-Specific CD8 T Cell Responses Using Interferon-Stimulated Gene 15 as an Immune Adjuvant.

Authors:  Carmen Elena Gómez; Beatriz Perdiguero; Michela Falqui; María Q Marín; Martina Bécares; Carlos Óscar S Sorzano; Juan García-Arriaza; Mariano Esteban; Susana Guerra
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

Review 2.  Regulation and action of interferon-stimulated gene 15 in breast cancer cells.

Authors:  Angeles C Tecalco-Cruz; Josué O Ramírez-Jarquín; Eduardo Cruz-Ramos
Journal:  Hum Cell       Date:  2020-08-19       Impact factor: 4.174

Review 3.  ISG15, a Small Molecule with Huge Implications: Regulation of Mitochondrial Homeostasis.

Authors:  Manuel Albert; Martina Bécares; Michela Falqui; Carlos Fernández-Lozano; Susana Guerra
Journal:  Viruses       Date:  2018-11-13       Impact factor: 5.048

4.  Viperin Differentially Induces Interferon-Stimulated Genes in Distinct Cell Types.

Authors:  Jeong Jin Kim; Ku Sul Kim; John Eom; Jae Bong Lee; Jun-Young Seo
Journal:  Immune Netw       Date:  2019-10-04       Impact factor: 6.303

Review 5.  Post-translational Control of Innate Immune Signaling Pathways by Herpesviruses.

Authors:  Jessica Carriere; Youliang Rao; Qizhi Liu; Xiaoxi Lin; Jun Zhao; Pinghui Feng
Journal:  Front Microbiol       Date:  2019-11-14       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.